Exclusive: Perceptic Aims to Automate Drug Discovery
Perceptic, a London-founded startup formed by former Palantir Life Sciences executives, launches from stealth with a ...
Perceptic, a London-founded startup formed by former Palantir Life Sciences executives, launches from stealth with a ...
A narrow, theme-driven ETF focused on generative AI shows mixed results as broader AI funds rally. The concentrated a...
SpaceX has filed for a $75 billion IPO valuing the company at about $1.75 trillion, signaling a watershed moment for ...
Planners say the key to retirement security lies in inflation adjusted dividend income, built from steady dividend gr...
As AI rivals surge and cloud demand shifts, investors question Microsoft’s staying power in the Magnificent 7. The de...
A CEO’s drastic HR purge and a high-profile EEOC lawsuit against The New York Times collide at a moment of market vol...
Bitcoin hovers around the $78,000 level as geopolitical headlines flash in the Middle East. Analysts warn the market ...
Bitcoin edges toward the $60,000 threshold as a $14 billion liquidation risk gathers in the futures market, threateni...
SpaceX is planning a NASDAQ debut with a monumental valuation, but the pre-IPO materials avoid a central issue: the q...
The stock market CAPE ratio has climbed near 40, a level last seen before major crashes in 1929 and 1999, prompting c...
Roundhill's DRAM ETF, with a 49% Korea weighting, has surged but faces overnight gaps as half its holdings trade when...
Natural gas equities are delivering higher yields than broad dividend ETFs as of 2026, driven by midstream cash flows...